Standardization efforts by IKWG aimed to improve the scoring consistency and to enhance clinical utility of Ki67 in routine practice resulting in global scoring is recommended by both ASCO and ESMO international breast cancer guidelines. Here, MKI67 is linked to breast carcinoma.